05.10.2015 12:52:38

Accuray, RaySearch Laboratories Sign New Long-term Collaboration Agreement

(RTTNews) - Accuray Inc. (ARAY) and RaySearch Laboratories AB have expanded on their existing relationship with the signing of a new long-term collaboration agreement.

The new agreement will lead to the integration of treatment planning support for the TomoTherapy and CyberKnife Systems in the RayStation treatment planning system or TPS.

RayStation is one of the most advanced independent treatment planning systems available. It will provide an ideal complement to the Accuray treatment delivery systems, enabling customers to choose the delivery technology that will best meet their needs.

Accuray and RaySearch previously announced a long-term collaboration regarding the RayCare oncology information system.

Accuray will have the opportunity to offer RayStation to clinicians who use the TomoTherapy and CyberKnife System product portfolios.

Accuray has an installed base of more than 500 TomoTherapy Systems and more than 300 CyberKnife Systems worldwide.

Treatment planning support for TomoTherapy Systems in RayStation is targeted for release during 2016, and support for CyberKnife Systems is scheduled for release during 2017.

Analysen zu Accuray IncShsmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Accuray IncShs 1,82 -1,09% Accuray IncShs